Wikipedia -WSS

Wikipedia

author：hotspot 2025-09-28 19:25:45 - browse：4424

Jennifer Doudna Feng Zhang CRISPR — CRISPR pioneers Jennifer Doudna and Feng Zhang Illustration: STAT; Photos: AP, Getty

The revolution started in silence.

Jennifer Doudna and Emmanuelle Charpentier, now Nobelists, published their first paper announcing a new enzyme for editing DNA in Science in June 2012. It was called CRISPR-Cas9. It wasn’t until January 2013 that the first paper showing the enzyme would work in cells, from Feng Zhang, was published, also in Science. A similar paper from George Church came out at the same time.

No major media outlet covered the papers. The first story on CRISPR was published that March. But within the ivory tower of academia, it was clear something big was building, as requests for the technology poured in from other researchers and Zhang set up an assembly line in his laboratory to distribute it, with students carrying carefully packed samples to a FedEx office down the street.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare proposal to cover medical devices draws a mixed reaction
Next article： More tobacco lobbyists active in statehouses

WSS

PBM reforms clear House panel

BIO: Crackdown on China pharma industry would threaten U.S. drug supply

Hospitals look to new technology to keep health care workers safe

Getting Alzheimer's drug Leqembi to patients can be a challenge

Why rehabilitation engineers need to center patients in their research

In key trial, Verve's treatment lowers cholesterol levels in patients

hotspot

Wikipedia

leisure time

Drug repurposing or repositioning? The language matters

David Sabatini, ex

Novavax promises a turnaround & Lilly roils the obesity market

Orangutan used medicinal plant to treat wound, first time ever seen

Psychedelics group wrestles with new pharma identity

Childhood cancer progress stalls for Black, Hispanic kids: Report

Guidelines to prevent youth baseball injuries need more muscle

Hospitals look to new technology to keep health care workers safe

ChatGPT in medicine: STAT answers readers' burning questions

Astellas still sees hope in its gene therapy after four deaths

explore

Cell therapy fails to slow type 1 diabetes, but safety is established

Cholera vaccine supply gets boost as demand surges globally

In key trial, Verve's treatment lowers cholesterol levels in patients

After traumatic brain injury, life support decisions can use more time

PBM reforms clear House panel

Buoyed by wins on obesity, Novo Nordisk eyes heart disease

entertainment

hotspot

explore

entertainment